Hanna Huopio1, Päivi J Miettinen1, Jorma Ilonen1, Päivi Nykänen1, Riitta Veijola1, Päivi Keskinen1, Kirsti Näntö-Salonen1, Jagadish Vangipurapu1, Joose Raivo1, Alena Stančáková1, Jonna Männistö1, Teemu Kuulasmaa1, Mikael Knip1, Timo Otonkoski1, Markku Laakso1. 1. Department of Pediatrics (H.H., J.M.), University of Eastern Finland, and Kuopio University Hospital, Kuopio, Finland; Children's Hospital (P.J.M., M.K., T.O.), University of Helsinki, and Helsinki University Hospital, Helsinki, Finland; Immunogenetics Laboratory (J.I.), University of Turku, and Turku University Hospital, Turku, Finland; Department of Pediatrics (P.N.), Mikkeli Central Hospital, Mikkeli, Finland; Department of Pediatrics (R.V.), Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland; Department of Pediatrics (P.K.), Tampere University Hospital, Tampere, Finland; Department of Pediatrics (K.N.-S.), Turku University Hospital, Turku, Finland; Institute of Clinical Medicine (J.V., J.R., A.S., T.K., M.L.), Internal Medicine, University of Eastern Finland, Kuopio, Finland; Institute of Clinical Medicine (M.L.), Internal Medicine, University of Eastern Finland, and Kuopio University Hospital, Kuopio, Finland.
Abstract
CONTEXT: Major advances have been made in the classification and genetics of monogenic diabetes in infancy. OBJECTIVE: The objective of the study was to characterize different forms of diabetes diagnosed during the first year of life. DESIGN: Patients diagnosed with diabetes before the age of 1 year in 10 Finnish hospitals from 1980 to 2014 were included. SETTING: The study was conducted at Kuopio University Hospital and University of Eastern Finland. PATIENTS: Patients were identified through diagnosis-based searches from hospital registries including 93 children, of whom 64 participated. INTERVENTIONS: DNA sample for sequencing, serum sample, and medical records interventions were included. MAIN OUTCOME MEASURES: Incidence of diabetes during the first year of life, sequencing results, human leukocyte antigen (HLA) genotypes, and islet autoantibodies were measured. RESULTS: The incidence of diabetes diagnosed during the first 12 months was 4.4/100 000/year. Three novel and 11 previously described mutations were found in 22 patients from 15 families in the KCNJ11, ABCC8, INS, GCK, FOXP, STAT3, and RFX6 genes. Positive islet autoantibodies were observed in 40.0% of the patients diagnosed during the first 0-6 months of life vs 70.8% of the patients diagnosed between ages of 7 to 12 months. A total of 85.7% of the patients carrying protective HLA genotypes were mutation-positive compared to 7.7% of the patients having high-risk genotypes (P = .001). CONCLUSIONS: Mutations in the K-ATP channel and INS genes were the most common cause of early diagnosed monogenic diabetes. After 6 months of age, patients with diabetes had high HLA risk genotypes and islet autoantibodies, reflecting the autoimmune character of diabetes in that age group.
CONTEXT: Major advances have been made in the classification and genetics of monogenic diabetes in infancy. OBJECTIVE: The objective of the study was to characterize different forms of diabetes diagnosed during the first year of life. DESIGN:Patients diagnosed with diabetes before the age of 1 year in 10 Finnish hospitals from 1980 to 2014 were included. SETTING: The study was conducted at Kuopio University Hospital and University of Eastern Finland. PATIENTS: Patients were identified through diagnosis-based searches from hospital registries including 93 children, of whom 64 participated. INTERVENTIONS: DNA sample for sequencing, serum sample, and medical records interventions were included. MAIN OUTCOME MEASURES: Incidence of diabetes during the first year of life, sequencing results, human leukocyte antigen (HLA) genotypes, and islet autoantibodies were measured. RESULTS: The incidence of diabetes diagnosed during the first 12 months was 4.4/100 000/year. Three novel and 11 previously described mutations were found in 22 patients from 15 families in the KCNJ11, ABCC8, INS, GCK, FOXP, STAT3, and RFX6 genes. Positive islet autoantibodies were observed in 40.0% of the patients diagnosed during the first 0-6 months of life vs 70.8% of the patients diagnosed between ages of 7 to 12 months. A total of 85.7% of the patients carrying protective HLA genotypes were mutation-positive compared to 7.7% of the patients having high-risk genotypes (P = .001). CONCLUSIONS: Mutations in the K-ATP channel and INS genes were the most common cause of early diagnosed monogenic diabetes. After 6 months of age, patients with diabetes had high HLA risk genotypes and islet autoantibodies, reflecting the autoimmune character of diabetes in that age group.
Authors: Arushi Varshney; Laura J Scott; Ryan P Welch; Michael R Erdos; Peter S Chines; Narisu Narisu; Ricardo D'O Albanus; Peter Orchard; Brooke N Wolford; Romy Kursawe; Swarooparani Vadlamudi; Maren E Cannon; John P Didion; John Hensley; Anthony Kirilusha; Lori L Bonnycastle; D Leland Taylor; Richard Watanabe; Karen L Mohlke; Michael Boehnke; Francis S Collins; Stephen C J Parker; Michael L Stitzel Journal: Proc Natl Acad Sci U S A Date: 2017-02-13 Impact factor: 11.205
Authors: Diego Balboa; Jonna Saarimäki-Vire; Daniel Borshagovski; Mantas Survila; Päivi Lindholm; Emilia Galli; Solja Eurola; Jarkko Ustinov; Heli Grym; Hanna Huopio; Juha Partanen; Kirmo Wartiovaara; Timo Otonkoski Journal: Elife Date: 2018-11-09 Impact factor: 8.140
Authors: Kashyap A Patel; Jarno Kettunen; Markku Laakso; Alena Stančáková; Thomas W Laver; Kevin Colclough; Matthew B Johnson; Marc Abramowicz; Leif Groop; Päivi J Miettinen; Maggie H Shepherd; Sarah E Flanagan; Sian Ellard; Nobuya Inagaki; Andrew T Hattersley; Tiinamaija Tuomi; Miriam Cnop; Michael N Weedon Journal: Nat Commun Date: 2017-10-12 Impact factor: 14.919
Authors: Matthew B Johnson; Kashyap A Patel; Elisa De Franco; William Hagopian; Michael Killian; Timothy J McDonald; Timothy I M Tree; Clara Domingo-Vila; Michelle Hudson; Suzanne Hammersley; Rebecca Dobbs; Sian Ellard; Sarah E Flanagan; Andrew T Hattersley; Richard A Oram Journal: Diabetologia Date: 2020-10-08 Impact factor: 10.122